baber/WOPTO huggingface dataset:
Patent NZ-329574-A (NZ)
Title: A height adjustable roller modesty screen for a table
Inventor: FOOTITT IAN
IPC: A47B17/00
Filed: 1998-01-13
Abstract: A roller assembly for a modesty screen attachable to a table of the figures 1 and 2 which comprises: a) an elongated, rigid axle having a non-linear configuration b) unitary, tubular, corrugated sleeve having an interior surface bounding a passageway longitudinally extending between a first end and an opposing second end, the axle being at least partially longitudinally disposed within the passageway, the corrugated sleeve having a configuration complementary to the non-linear configuration of the rigid axle, the corrugated sleeve being sufficiently flexible to selectively rotate about the axle while maintaining the configuration complementary to the non-linear configuration of the rigid axle.
Patent NZ-332707-A (NZ)
Title: Use of dipeptidyl peptidase iv inhibitors (dpiv) for lowering the blood glucose level in mammals
Inventor: DEMUTH HANS-ULRICH
IPC: A61K39/395
Filed: 1997-04-24
Abstract: Use of "effectors" of dipeptidyl peptidase IV (DP IV) activity for lowering the blood sugar level below the glucose concentration characteristic of hyperglycaemia in the serum of a mammal is new.
Patent NZ-333792-A (NZ)
Title: Electromagnetic treatment device comprising a magnetic flux generator
Inventor: HOLCOMB ROBERT R
IPC: A61N1/08
Filed: 1996-06-19
Abstract: A therapeutic electromagnetic treatment device 10, for placement against the bodies of living animals comprises a magnetic flux generator 12 and a power source 14.  The generator 12 includes a plurality of electromagnetic bodies 18, 20, 22, 24 having at least four magnetic poles substantially in a single plane, the magnetic poles being oriented to define the four vertices of a quadrilateral shape.  Each of the magnetic poles exerts a magnetic force on the other three poles when the poles are electrically charged.  Containment means hold the magnetic poles of the magnetic bodies in the above described configuration.  The device may include a ferroconductor flux return ring 16a bolted to the end of the pole which in use is turned away from the animal or human along with a ferromagnetic focusing ring 16 which contains a ferroconductor metal ring and an electromagnet of the same polarity as the pole attached to the focusing ring in proximity to the four poles of the quadrilateral shape.
Patent NZ-336907-A (NZ)
Title: Radiation sources, typically ultra-violet, located in canal and aligned axially, with turbulence increasing devices between sources
Inventor: WHITBY G ELLIOTT
IPC: B01F5/00
Filed: 1998-01-05
Abstract: Apparatus for treating water flowing in a canal by radiation is disclosed. Lamps, typically UV, are aligned axially with the canal axis. Turbulent mixing is increased by positioning devices, such as washers, between lamp units in the system. The washers may have the same or different diameters. Turbulent mixing may also be increased by retaining the upstream end of each lamp unit in a ring-shaped device, alone or in combination with washers positioned on each lamp unit exterior surface as described above.
Patent NZ-503745-A (NZ)
Title: Method of dispersing an insoluble material in an aqueous solution and an agricultural formulation
Inventor: KIRBY ANDREW FRANCIS
IPC: C05G3/70
Filed: 1998-10-14
Abstract: A method of dispersing an insoluble material in an aqueous solution comprising the following steps: (i) providing a formulation comprising at least one insoluble material and at least one dispersant comprising a water soluble agriculturally acceptable derivative of an alternating copolymer wherein the alternating copolymer comprises at least one residue of a first comonomer and at least one residue of a second comonomer, wherein the first comonomer comprises alpha-, beta- unsaturated oxyacids or anhydrides and the second comonomer comprises olefinic compounds containing one or more polymerizable double bonds; and (II) dispersing the formulation in an aqueous medium.
Patent NZ-506713-A (NZ)
Title: Plant-gene promoter encoding a Douglas fir metallothionein-like protein (dfMTP)
Inventor: MISRA SANTOSH
IPC: C12N15/82
Filed: 2000-09-04
Abstract: A promoter from Douglas-fir genes encoding metallothionein-like proteins. Also provided are deletions and variants of such promoters. The promoters are useful for, among other things, directing developmental-specific expression of transgenes.
Patent NZ-509736-A (NZ)
Title: Stamped Y-shaped hinge construction, especially for items of jewellery
Inventor: PETERS JOHN
IPC: A44C27/00
Filed: 1999-08-05
Abstract: A hinge construction, especially for items of jewellery, specifically earrings of the type known as "creole" earrings. Such earrings have a looped body (14A) defining ends (60) which are spaced to accommodate the ear lobe. A hinge bar (24) connects the ends (60) by being hinged to one end and being releasable clasped to the other end. The hinge bar (24) is a plate stamping and is Y shaped at one end (42), and the hinge pin (44) is formed as the cross bar (44) of an H shaped plate stamping, which is soldered to the earring body (14A). To connect the bar (24) to the pin (44) the Y shaped end is located so that the arms (46, 48) of the Y lie to opposite sides of the pin (44), and then the arms (46, 48) are bent round the pin (44) completing the hinge.
Patent NZ-517561-A (NZ)
Title: Nacrocyclic compounds formed by the fermentation of a Phoma sp. strain
Inventor: INUKAI MASATOSHI
IPC: C07K7/06
Filed: 2000-08-31
Abstract: Compounds of formula (I) are disclosed, wherein these compounds exhibit antifungal activity, and are useful in treating and preventing fungal infectious diseases.  A process for the preparation of this compound by isolating the compound from the fermentation product of a microorganism producing this compound is also disclosed.
Patent NZ-528913-A (NZ)
Title: Split-flow, vertical ammonia converter
Inventor: BLANCHARD KENNETH L
IPC: C01C1/04
Filed: 2003-10-15
Abstract: A vertical, fixed-bed ammonia converter wherein a fixed-bed catalyst zone is configured into two mechanically separated catalyst volumes and two gas streams that operate in parallel. The design maintains the ratio of gas flow to catalyst volume so that there is no catalyst effectiveness penalty. The catalyst beds and gas flow paths are configured so that gas flow is downward through each catalyst volume. Each fixed-bed catalyst zone can hold the catalyst in an annular space formed between two concentric shrouds arranged around a shell and tube heat exchanger. The two catalyst beds associated with each zone are situated above one another along the length of an interstage heat exchanger. Pipes or conduits are disposed through the beds to effect the parallel gas flow configuration, or alternatively, annular flows are created via passages through the internal shrouds that contain the catalyst beds.
Patent NZ-531023-A (NZ)
Title: Foundation structure, components therefor and method of constructing a foundation
Inventor: BAKER COLIN LAWRENCE MELVIN
IPC: E02D27/02
Filed: 2002-07-09
Abstract: A foundation component (1) is disclosed which is suitable for forming part of a modular foundation for a building structure. The foundation component (1), defines at least one receptacle (2) which, in use, may be filled with a suitable particulate material. A plurality of protrusions (5) extending generally downwards from the base (6) of the foundation component (1) engage a foundation surface on which the foundation component is located. In a preferred embodiment the foundation component may include tongue in groove interengagement of adjacent foundation components (1), and may also include provision for service channels and reinforcing rods.
Patent NZ-532275-A (NZ)
Title: Record carrier and apparatus for scanning the record carrier
Inventor: SCHEP CORNELIS MARINUS
IPC: G11B20/00
Filed: 2002-09-24
Abstract: A record carrier (1) is described which has a servo track (4) indicating an information track (9) intended for recording information blocks. The servo track (4) has a periodic variation of a physical parameter at a predetermined frequency, usually called wobble. the servo track has modulated parts for encoding position information according to a predetermined type of modulation. The record carrier comprises a management area in which the servo track comprises permanent data. The permanent data is encoded using a different type of modulation, but using the variations of the same physical parameter. Direct digital modulation (41) is proposed for the different type of modulation. Further a device for reading and/or writing the record carrier is described.
Patent NZ-533095-A (NZ)
Title: Fluid analyser systems with light radiation of sealed receptacle
Inventor: MOOR TIMOTHY NICHOLAS
IPC: G01N33/497
Filed: 2002-11-21
Abstract: Fluid analyser systems are provided which can detect a multitude of fluids in a sample to a very high level of accuracy which includes the detection of the presence of very small amounts of fluids. The results are both qualitative and quantitative. The systems consist of a receptacle which is filled with the fluid sample to be analysed which is placed into a consistent light condition environment where its temperature is measured. Under a predetermined time duration, Charge-Coupled Device (CCD) detector(s) receive by absorbance, radiation from the fluid sample at known wavelengths and are matched against a databank of known wavelengths of fluids. Matching wavelengths within a pre-defined tolerance will determine whether an individual fluid is present or not.
Patent NZ-537036-A (NZ)
Title: Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
Inventor: DELUCA HECTOR F
IPC: C07C401/00
Filed: 2001-07-10
Abstract: Disclosed is the use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3, of formula (I) in the preparation of a medicament for increasing the strength of a bone in bone replacement procedures.
Patent NZ-537785-A (NZ)
Title: Method for the separation of intermediates that are used in the preparation of escitalopram
Inventor: PETERSEN HANS
IPC: C07B57/00
Filed: 2003-08-12
Abstract: A method for the preparation of diol intermediates having the formula (II) and/or the opposite enantiomer of an acylated diol having the formula (IV) useful for the preparation of escitalopram involving selective enzymatic acylation or deacylation is disclosed.
Patent NZ-543167-A (NZ)
Title: Method and system for controlling access to presence information on a peer-to-peer basis
Inventor: BARKLEY WARREN VINCENT
IPC: G06F/
Filed: 2005-10-25
Abstract: A method and system that allows access to presence information of a publishing entity to be controlled by the publishing entity and enforced by its computer system on a peer-to-peer basis, rather than by a presence server. When the publishing entity receives a request to subscribe to its presence information, the presence information system on its computer system can allow or deny the request based on access rights associated with the subscribing entity. A publishing entity may define access rights at various levels of detail of presence information, by way of a hierarchy of presence states, so that different subscribing entities may have access to different levels of presence information. The presence information system may also allow a publishing entity to define multiple presence models and to expose different presence models to different subscribing entities.
Patent NZ-543756-A (NZ)
Title: Manipulation of flowering and plant architecture using Lolium homeo-box (HB) protein
Inventor: SPANGENBERG GERMAN
IPC: A01H5/00
Filed: 2001-10-17
Abstract: Disclosed is a substantially purified or isolated nucleic acid fragment encoding a Homeo-box protein (HB) from a Lolium species or a functionally active fragment or variant thereof. The nucleic acid can be introduced into a plant to modify plant life cycles and/or growth phases, flowering processes, flowering and/or plant architecture and flower and/or inflorescence development in a plant, or can be used as a molecular marker.
Patent NZ-544328-A (NZ)
Title: Bone plate
Inventor: GRADY MARK P
IPC: A61B17/56
Filed: 2004-05-28
Abstract: The present disclosure is directed to a bone plate and its method of use for reducing a bone fracture, the bone plate having a longitudinal axis, the bone plate comprising an upper surface, a lower surface, a first hole for engaging a head of a first bone anchor. The first hole is configured and adapted to fix a shaft of the first bone anchor along a first axis. A second hole is spaced apart from the first hole along the longitudinal axis. The second hole is for engaging a head of a second bone anchor, and is configured and adapted to fix a shat of the second bone anchor along a second axis. The first hole and the second hole are configured such that the first axis and the second axis define a single plane and intersect at a point below the lower surface. The shafts of the first and second bone anchors may touch or nearly touch at the point of intersection, such that the first and second bone anchors form a truss.
Patent NZ-552015-A (NZ)
Title: Structure for use in seawater, wire-shaped or rod-shaped copper alloy material for constituting the same, and process for production thereof
Inventor: OISHI KEIICHIRO
IPC: B22D1/00
Filed: 2005-08-10
Abstract: Disclosed is a copper alloy material in wire or bar form for forming a netted structure used in seawater, the copper alloy material comprising a composition containing: 62 to 91 mass% of CU; 0.6 to 3 mass% of Sn; optionally contains at least one element Xl selected from the group consisting of 0.02 to 0.25 mass% of As, 0.02 to 0.25 mass% of Sb, 0.001 to 0.2 mass% of Mg, and 0.01 to 0.25 mass% of P; optionally contains at least one element X2 selected from the group consisting of 0.02 to 1.5 mass% of AI, 0.05 to 1.5 mass% of Mn, 0.02 to 1.9 mass% of Si and 0.005 to 0.5 mass% of Ni; and the balance being Zn; wherein the composition satisfies the relationship derived from the Cu content [Cu] , Sn content [Sn] , P content [P], Xl total content [Xl] except P, Al content [AI], Mn content [Mn] , Si content [Si], and Ni content [Ni] in terms of mass%: 62 less than or equal to [Cu]-0.5[Sn]-3 [P]0.5[X1] -3.5[Si] -1.8[AI]+[Mn]+[Ni] less than or equal to 90, wherein the copper alloy material has a phase structure including an alpha phase, a gamma phase, and a delta phase, and the total area ratio of the alpha, gamma and delta phases is 95 to 100%.
Patent NZ-553315-A (NZ)
Title: Fusobacterium polypeptides and methods of use
Inventor: EMERY DARRYLL A
IPC: C07K14/195
Filed: 2005-08-25
Abstract: Provided is a composition comprising: at least two isolated polypeptides having molecular weights between 86 kDa and 24 kDa, wherein molecular weight is determined y electrophoresis on a sodium dodecyl sulphate polyacrylamide gel, wherein the polypeptides are isolatable from a Fusobacterium spp. when incubated in medium comprising a metal chelator and not isolatable when grown in the medium without the metal chelator. Also provided are uses of the composition for the manufacture of a medicament to treat Fusobacterium caused diseases.
Patent NZ-556443-A (NZ)
Title: Rocker switch with a modular indicator system where the indicator connects to the switch terminals
Inventor: POLI MASSIMILIANO
IPC: H01H9/16
Filed: 2005-12-15
Abstract: A switch (1) with an indicator (6) is disclosed. The switch (1) has a planar trim plate topped by a rocker actuator (2) which is mounted with its lower face on a mechanism (3) equipped with connection terminals. A signalling or indicator light (6) is housed in the mechanism (3) in an opening across the trim plate below a translucent part of the actuator (2). The indicating light (6) is provided with a terminal block for electrical connection to the terminals of the switch. This is achieved by linking the terminal block of the indicator (6) to the terminals of the switch (1).
Patent NZ-564570-A (NZ)
Title: Metal folding apparatus
Inventor: AIMERS RICHARD JAMES
IPC: B21D5/01
Filed: 2007-12-18
Abstract: An incremental metal folding apparatus is provided. The apparatus includes a folding mechanism, a feed arrangement and a clamp arrangement. The folding mechanism is configured to move so as to tangentially fold metal stock, the feed arrangement is configured to move metal stock through the folding mechanism, and the clamp arrangement is configured to hold metal stock while it is being folded. The folding mechanism, feed arrangement and clamp arrangement are arranged to work together to perform a number of spaced incremental tangential folding operations so as to build up a fold from a number of incremental folds.
Patent NZ-572376-A (NZ)
Title: Improved antimicrobial peptides
Inventor: SCHMIDTCHEN ARTUR
IPC: A61K38/04
Filed: 2007-05-15
Abstract: Provided is an antimicrobial peptide with increased antimicrobial activity comprising a) a first set of amino acid residues having a length of 10, 11, 12, 13, 14, 15,16,17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35 or36 amino acid residues, wherein said first set of amino acid residues has antimicrobial activity, is hydrophilic and is highly positively charged; and b) a second set of amino acid residues consisting of 3,4 or 5 hydrophobic amino acid residues selected from the group consisting of V, L, I, F, Y and W, and wherein said second set of amino acid residues is linked to the amino or carboxy terminal end of said first set of amino acid residues, thereby obtaining said antimicrobial peptide with increased antimicrobial activity.
Patent NZ-573129-A (NZ)
Title: Piperazine acetic acid glycine transporter-1 inhibitors
Inventor: HITCHCOCK STEPHEN
IPC: A61K31/495
Filed: 2007-06-26
Abstract: Disclosed are piperazine acetic acid glycine transporter-1 compounds represented by general formula (I), or pharmaceutically acceptable salts thereof, wherein the substituents are defined in the specification. Also disclosed is the use of the above mentioned compounds of formula (I) for treating a disease treatable by the inhibition of GlyT1 receptor.
Patent NZ-574362-A (NZ)
Title: 3'-ethynylcytidine derivative
Inventor: TANAKA MOTOAKI
IPC: A61K31/7068
Filed: 2007-07-23
Abstract: Disclosed are 3'-ethynylcytidine derivatives represented by formula (1) which have a cytosine moiety wherein the variables are as defined in the specification. These compounds are suitable for use as anti tumor drug. Also disclosed is a pharmaceutical composition, an oral anti tumor drug and the use to make a medicament.
Patent NZ-574487-A (NZ)
Title: Increasing the water permeability of porous polymeric membranes using monopersulfate and halide ions
Inventor: MULLER HEINZ-JOACHIM
IPC: B01D65/02
Filed: 2007-07-13
Abstract: Disclosed is a method of increasing the water permeability of a porous polymeric membrane and/or cleaning a porous polymeric membrane. The disclosed method comprises the step of contacting said porous polymeric membrane with a source of monopersulfate and a halide ion.
Patent NZ-578493-A (NZ)
Title: Compositions of tiacumicins stabilized with antioxidants
Inventor: SANGHVI SUKETU
IPC: C07H17/08
Filed: 2008-01-17
Abstract: Disclosed is a pharmaceutical composition to treat or prevent C. difficile infection in a subject, comprising a therapeutically effective amount of one or more tiacumicins, a stabilizing amount of one or more antioxidants, and one or more pharmaceutically acceptable excipients, wherein one or more tiacumicins is Difimicin, also described as 3-[[[6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-D-mannopyranosyl]oxy]-methyl]-12(R)-[[6-deoxy-5-C-15 methyl-4-O-(2-methyl-1-oxopropyl)-D-lyxohexopyranosyl] oxy]-11(S)-ethyl-8(S)-hydroxy-18(S)-(1(R)hydroxyethyl)-9,13,15-trimethyloxacyclooctadeca- 3,5,9,13,15-pentaene-2-one the composition is in a solid dosage form wherein the infection is C. difficile-associated diarrhea (CDAD), colitis, pseudomembranous colitis, antibiotic associated diarrhea antibiotic-associated enterocolitis, sporadic enterocolitis, nosocomial enterocolitis, colitis membranous, infectious diarrhea, and irritable bowel syndrome.
Patent NZ-582692-A (NZ)
Title: Pyrimidyl cyclopentanes as akt protein kinase inhibitors
Inventor: BENCSIK JOSEF R
IPC: A61P35/00
Filed: 2008-07-03
Abstract: Disclosed is a piperazine substituted cyclopenta[d]pyrimidine compound of formula (I) where the substituents are as disclosed in the description. Examples of compounds of formula (I) are: (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-fluoro-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-2-((S)-pyrrolidin-2-yl)ethanone; (S)-2-(4-chlorophenyl)-1-(4-((5R,7S)-7-fluoro-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-2-((S)-pyrrolidin-2-yl)ethanone; (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5Hcyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-2-((S)-pyrrolidin-2-yl)ethanone. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for treating an AKT-mediated disease or disorder in a mammal such as inflammatory, hyperproliferative, cardiovascular, neurodegenerative, gynaecological, or dermatological disease. Further disclosed is a kit comprising a compound of formula (I) and a process for preparing a compound of formula (I).
Patent NZ-583429-A (NZ)
Title: Peptides and proteins capable of inhibiting and/or preventing mast cell activation
Inventor: MILBURN PETER J
IPC: A61K38/02
Filed: 2008-08-25
Abstract: Disclosed is polypeptide for modulating mast cell activation, said polypeptide comprising a NEDD 9 Src homology 3 (SH3) domain sequence that consists of a sequence as set forth in SEQ ID NO: 8 or a variant or fragment thereof wherein: (i) the variant consists of a sequence as set forth in anyone of SEQ ID NOs: 16, 33-49,145-148, 156-159, 165-168, or 176-179; and (ii) the fragment consists of a sequence as set forth in anyone of SEQ ID NOs: 122-125, or 134-137. Also disclosed is the use of a polypeptide comprising a NEDD9 Src homology 3 (SH3) domain ammo acid sequence for the manufacture of a medicament for the treatment of a hypersensitivity disease or disorder arising from mast cell activation
Patent NZ-583551-A (NZ)
Title: Catecholamine derivatives and prodrugs thereof
Inventor: JORGENSEN MORTEN
IPC: C07D221/08
Filed: 2008-08-28
Abstract: Catecholamine derivatives of formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in therapy is disclosed, wherein the variables shown in the structure of formula (I) are as defined in the specification. These compounds are suitable for the treatment of psychoses, impotence, renal failure, heart failure, hypertension, cognitive impairment, restless legs syndrome (RLS) or periodic limb movement disorder (PLMD) movement disorders, poverty of movement, dyskinetic disorders, gait disorders, intention tremor in a mammal, and neurodegenerative disorder such as Parkinson's disease or Huntington's disease.
Patent NZ-586486-A (NZ)
Title: Pyrrolopyrimidinecarboxamides
Inventor: STADLWIESER JOSEF
IPC: A61K31/519
Filed: 2009-02-25
Abstract: Disclosed is a compound of formula (I) e.g. 4-(5-Cyclopropylmethoxy-1,3-benzodioxol-4-yl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic acid (1- propionyl-piperidin-4-yl)-amide, wherein the variables are defined in the specification a salt thereof, an N-oxide of the compound or the salt thereof or a stereoisomer of the compound, the salt, the N-oxide of the compound or the N-oxide of the salt thereof for the treatment or prophylaxis of portal hypertension, liver cirrhosis, toxic liver damage, hepatitis, non-alcoholic steatohepatitis or liver fibrosis.